Recursion is seeking an Executive Director, Asset Strategy Leadership, to drive asset strategy for small molecule programs in oncology and immunology/inflammation. Hybrid, office-based in New York City, with collaboration across clinical development, platform, and BD teams.
The role focuses on translating Recursion OS insights into strategic advantages and ensuring portfolio decisions are data-driven and patient-centric.
#J-18808-LjbffrExecutive Director, AI-Driven Asset Strategy in new york at Unknown Company
This position is listed as full time and hybrid.